Clinical Trials on Pleural Infection in Belgium

Total 1545 results

Janssen Vaccines & Prevention B.V.

Completed

A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Respiratory Syncytial Virus Infection Prevention

Germany, Spain, Belgium, Sweden, United States
Francis Corazza

Completed

Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome

COVID-19

Belgium
University Hospital, Ghent

Completed

Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic (ONCOVID)

Cancer

Belgium
Centre Hospitalier Universitaire Saint Pierre
AbbVie; Gilead Sciences; Cepheid; Réseau Hépatite C Bruxelles

Completed

HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels

Hepatitis C, Chronic

Belgium
University of Liege

Active, not recruiting

Impact of DOlutegravir+Lamivudine Simplification on HIV-1 Reservoirs (IDOLTIB)

HIV Infections

Belgium
Institute of Tropical Medicine, Belgium
Sciensano

Completed

Development and Implementation of an HIV-testing Intervention for Primary Care in Belgium

HIV Infections

Belgium
Novartis

Completed

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Pertussis

Belgium
International Partnership for Microbicides, Inc.
Tibotec Pharmaceutical Limited

Completed

Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium

HIV Infections

Belgium
KU Leuven

Completed

Recognition of Serious Infections in the Elderly (ROSIE)

Infection

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia

Staphylococcus Aureus Bacteraemia

Belgium
Institute of Tropical Medicine, Belgium
University Hospital, Antwerp

Completed

Treponema Pallidum-specific Proteomic Changes in Patients With Incident Syphilis Infection (SeTPAT)

Syphilis

Belgium
Cliniques universitaires Saint-Luc- Université...
Université Catholique de Louvain

Completed

Pharmacogenetics of Antiretroviral Drugs

HIV Infections

Belgium
International Partnership for Microbicides, Inc.

Completed

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

HIV Infections

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule

Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule

Hepatitis A

Belgium
Erasme University Hospital
Université Libre de Bruxelles; King Baudouin Foundation

Completed

Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.

Loneliness | Resilience, Psychological | Surveys and Questionnaires | Youth

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19

Covid19 | Hypoxemia

Belgium
GlaxoSmithKline

Completed

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

HIV Infections | AIDS

Belgium
International Partnership for Microbicides, Inc.

Completed

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium

HIV Infections | HIV-1

Belgium
Institute of Tropical Medicine, Belgium

Recruiting

Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk (POQS-FU PLUS)

Monkeypox

Belgium
Novartis

Completed

Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults

Typhoid Fever

Belgium
University Ghent

Completed

Community Health Workers Against COVID19

Covid 19 | Mental Health Impairment | Social Isolation

Belgium
GlaxoSmithKline

Withdrawn

Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®

Hepatitis A

Belgium
Institute of Tropical Medicine, Belgium

Completed

Monkeypox ASymptomatic Shedding: Evaluation by Self-Sampling MPX-ASSESS (MPX-Assess)

Monkey Pox

Belgium
Institute of Tropical Medicine, Belgium

Completed

Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea (ResistAZM)

Neisseria Gonorrhoeae

Belgium
GlaxoSmithKline
Novartis Vaccines

Completed

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

Streptococcal Infections | Infections, Streptococcal

United States, Belgium, Czechia
Hasselt University
Ziekenhuis Oost-Limburg

Completed

Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections (RUNtoBBV)

Hepatitis B | Human Immunodeficiency Virus | Hepatitis c

Belgium
Polichem S.A.

Completed

Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population

Onychomycosis

Belgium, Germany, Italy, Latvia, Spain
Osivax
Center for vaccinology (CEVAC), University of Ghent

Completed

Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.

Influenza

Belgium
Osivax
Centre for vaccinology (CEVAC), University of Ghent

Completed

Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years

Influenza

Belgium
Osivax
Center for vaccinology (CEVAC), University of Ghent, Belgium

Completed

A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

Influenza

Belgium
GlaxoSmithKline

Completed

Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population

Influenza

Belgium
Seqirus
Novartis Vaccines

Completed

Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

Influenza

Belgium
Visterra, Inc.

Completed

Influenza Challenge Study of VIS410 in Healthy Volunteers

Influenza

Belgium
Crucell Holland BV

Completed

Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine

Influenza

Belgium
Novartis
Novartis Vaccines

Completed

A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age

Influenza

Belgium
Crucell Holland BV

Completed

Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine

Hepatitis A

Belgium
GlaxoSmithKline

Completed

A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays

Infections, Streptococcal

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Gut Microbiota, PGx and INSTIs Response

HIV Infections

Belgium
University Hospital, Ghent

Completed

Impact of COVID-19 on Mental Health of Health Care Workers (COVID-Impact)

Quality of Life | Mental Health

Belgium
Brugmann University Hospital

Completed

Mortality Due to COVID-19 in the COVID-AGEBRU Study (COVID-AGEBRU)

Covid19 | Old Age; Debility | Morbidity, Multiple

Belgium
Centre Hospitalier Universitaire Saint Pierre

Completed

Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19

COVID-19 | Anosmia

Belgium
Jessa Hospital

Terminated

Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR

Covid-19 | SARS-CoV-2 | Diagnosis | Polymerase Chain Reaction

Belgium
Hasselt University

Unknown

Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg (HBVTR)

Hepatitis B

Belgium
Brugmann University Hospital

Completed

Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19 (SARCO-V)

Sarcopenia

Belgium
Cyril Barbezange
Sciensano; Belgian Federal Public Service, Food Chain Safety and Environment; Agentschap Zorg en Gezondheid

Enrolling by invitation

Zoonotic Influenza Surveillance in Belgium (ZOOIS)

Influenza, Human

Belgium
Osivax
Aepodia

Completed

Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects

Influenza

Belgium

3

Subscribe